David and Beatrix Hamburg Award for Advances in Biomedical Research and Clinical Medicine
The National Academy of Medicine’s annual David and Beatrix Hamburg Award honors innovative biomedical scientists advancing global health. Named after David Hamburg, former Institute of Medicine president (1975-1980), and Beatrix Hamburg, a child and adolescent behavioral health expert, the award includes a medal and $50,000. Established in 2004 through an endowment celebrating the Hamburgs’ legacy, the awards are presented at the NAM Annual Meeting each October.

Open until May 15
Nominations for NAM Awards are now open!
Please help the NAM recognize deserving individuals – nominate a colleague today!
Selection Criteria
Each year, a selection committee appointed by the National Academy of Medicine considers the following criteria when determining the winner of the Hamburg Award. The Hamburg Award is awarded to one or more scientists in recognition of an exceptional biomedical research discovery and/or translation that has fundamentally enriched our understanding of human biology and disease, leading to a significant reduction of disease burden and improvement in human health.
Award Criteria:
Principal selection criteria
- Discovery, translation, or public health intervention of impact which has led to improvement in human health and/or reduction in health inequities; and
- Innovative, creative, and pioneering achievement; and
- The nominee(s)’ unique contributions to the achievement
- Achievement was not previously recognized by a substantive international award
Additional selection criteria
- Demonstration of a qualitative and quantitative impact on health disparities
- Interdisciplinary science and collaborations are positively viewed
2024 Recipients

Gordon James Freeman
Professor of Medicine
Dana-Farber Cancer Institute, Harvard Medical School
Arlene Helen Sharpe
Kolokotrones University Professor
Chair of the Department of Immunology
Harvard Medical School
History
The Hamburgs
“I am so pleased that this award has been created in my parents’ name, and will honor their legacy and commitment to excellence and innovation in biomedical sciences. My parents were both psychiatrists by training but throughout their careers fostered and supported advances in basic and clinical science, especially those that were accomplished in collaboration across fields of expertise and that worked to improve the human condition. I am very much looking forward to honoring individuals who have exhibited the potential to benefit humanity through this award, and encourage all who can to submit an application in January 2022.”
— Margaret “Peggy” Hamburg, vice president for biological programs and policies at the Nuclear Threat Initiative, and former international secretary of the NAM
